Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
1
17%
Ph phase_3
5
83%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
5(83.3%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 35 (83.3%)
Phase 41 (16.7%)

Trials by Status

terminated117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_4

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion

NCT04792970
completedphase_3

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

NCT00002872
completedphase_3

Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

NCT02674243
completedphase_3

Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer

NCT00042770
completedphase_3

Talc in Treating Patients With Malignant Pleural Effusion

NCT00002622
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04792970Phase 4

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion

Terminated
NCT00002872Phase 3

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

Completed
NCT02674243Phase 3

Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

Completed
NCT00042770Phase 3

Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer

Completed
NCT00002622Phase 3

Talc in Treating Patients With Malignant Pleural Effusion

Completed
NCT00821860Phase 3

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6